Medical AI Alliance
← Company Index
Pharma & CDMOKOSDAQ 17675010 approvals

DuChemBio Co, LTD

Official website

Founded 2002, KOSDAQ-listed 2024, DuChemBio makes radiopharmaceuticals FDG, FP-CIT, Neuraceq, and Vizamyl.

As of 2026-10-11, DuChemBio Co, LTD has 10 Korean MFDS drug approvals on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

DuChemBio was founded in 2002 and listed on KOSDAQ in December 2024 as a developer, manufacturer, and seller of radiopharmaceuticals. Its main products include FDG injection, FP-CIT injection, Neuraceq injection (florbetaben), Vizamyl injection (flutemetamol), and an 18F-FDOPA injection, and in August 2024 the company completed acquisition of 100% equity in Radio D&S Labs, a radiopharmaceutical R&D firm. DuChemBio operates 12 manufacturing sites, including 6 GMP-certified facilities, and in 2025 posted revenue of KRW 38,572 million (up 8.3% year-on-year) and operating profit of KRW 7,443 million (up 46.6%), with the FDG product line accounting for 57.1% of sales, the Alzheimer's diagnostic product line 19.4%, and the FP-CIT product line 9.9%.

Products & technology

  • FDG injectionDiagnosis of tumors with glucose metabolism
  • FP-CIT injectionMeasurement of striatal dopamine transporter density for diagnosis of Parkinson's disease and Parkinsonian syndrome
  • Neuraceq injection (18F-florbetaben)Measurement of beta-amyloid distribution and density for Alzheimer's diagnosis
  • Vizamyl injection (18F-flutemetamol)Measurement of beta-amyloid distribution and density for Alzheimer's diagnosis
  • 18F-FDOPA injectionDiagnosis of brain tumors and neuroendocrine tumors; diagnosis of Parkinson's disease and differentiation of Parkinsonian syndrome

Regulatory approvals

data.go.kr

10 Korean MFDS drug approvals · 2004–2025

  • MFDS drugDuchembio_FES_injection(Fluoro Estradiol (18F) liq.)2025-12-18
    Drug · Prescription · Approval202503306
  • MFDS drugProstaseek injection(Flotufolastat F18 liq.)2025-07-22
    Drug · Prescription · Approval202501845
  • MFDS drugDuchembio FP-CIT injection2025-01-21
    Drug · Prescription · Approval202500157
  • MFDS drugFACBC injecton2021-09-17
    Drug · Prescription · Approval202106591
  • MFDS drugDopaceq Injection2019-10-22
    Drug · Prescription · Approval201907382
  • MFDS drugVizamyl(flutemetamol(18F)2015-08-25
    Drug · Prescription · Approval201506003
  • MFDS drugMetascan Injection2015-01-30
    Drug · Prescription · Approval201500482
  • MFDS drugDuchembio FDG-102013-03-06
    Drug · Prescription · Approval201306043
  • MFDS drugDuchembio FDG Pre-filled Syringe Injection2011-01-03
    Drug · Prescription · Approval201100003
  • MFDS drugDuchembio FDG-20Revoked2004-09-06
    Drug · Prescription · Approval200404907

Key disclosures

KRX KIND via OpenDART

Patents

KIPRIS · applicant-matched
Show 1 more patents

AI reads

MAA server logs · IP-verified
28
Times AI engines pulled DuChemBio Co, LTD's records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

1
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

27
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

3
live 0
Last 7 days
21
live 0
Last 30 days
28
live 1
All time
  • OpenAIChatGPT-Userlive1
  • OpenAIOAI-SearchBot22
  • GoogleGoogleOther2
  • AnthropicClaudeBot2
  • PerplexityPerplexityBot1

Measured since Aug 27, 2026 · 4 AI engines · last read Oct 10, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for DuChemBio Co, LTD and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview · R&D. Send us materials and we will add them

Companies in the same categoryPharma & CDMO

ILDONG HOLDINGS CO.,LTD100

Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.

Yuyu Pharma, Inc.100

Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.

IL DONG PHARMACEUTICAL CO., LTD.100

Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.

Medy-Tox Inc.99

Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.

GC Biopharma Corp.97

KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.

DAEWON PHARMACEUTICAL CO.,LTD85

KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.

SAMSUNG BIOLOGICS CO.,LTD.85

Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.

GENOLUTION INC.85

Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.

AHN-GOOK PHARMACEUTICAL Co., Ltd.85

Ahn-Gook Pharmaceutical sells the cough/expectorant drug Sinecuran and the eye-health supplement Tobicom.

CORESTEMCHEMON Inc.85

Founded in 2003 and listed on KOSDAQ in 2015, Corestem Chemon develops stem cell therapies and provides nonclinical CRO services, including the ALS treatment Neuronata-R.

BIO-FD&C CO.,LTD.85

Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.

HANDOK Inc.85

KOSPI-listed comprehensive pharma company behind Amaryl diabetes drug and the USD 86.25M HL5101 anticancer out-license deal.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition